Medical application of gabapentin

A technology of gabapentin and its application, which is applied in the field of drugs used by gabapentin for the treatment of cerebral ischemia or cerebral infarction to achieve exact treatment and prevention effects, significant treatment and prevention effects, and effects of reducing sudden death rate

Inactive Publication Date: 2013-11-13
LUNAN PHARMA GROUP CORPORATION
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on the use of gabapentin in the treatment of cerebra

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical application of gabapentin
  • Medical application of gabapentin
  • Medical application of gabapentin

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0022] Example 1 Preparation of gabapentin tablets

[0023]

[0024] Preparation process: Weigh the prescribed amount of gabapentin, starch, dextrin and low-substituted hydroxypropyl cellulose and mix them evenly. Take another appropriate amount of 60% ethanol, add it to the mixed powder, mix evenly to make soft material, pass through a 16-mesh sieve to granulate, and dry below 60°C. After drying, use an 18-mesh sieve to sizing, sieve out the fine powder in the dry granules, mix them with the sieved magnesium stearate, and then mix them with the dry granules evenly, press the tablet, and get it.

Example Embodiment

[0025] Example 2 Preparation of gabapentin tablets

[0026]

[0027]

[0028] Preparation process: Weigh the prescribed amount of gabapentin, microcrystalline cellulose and hydroxypropyl cellulose and mix them evenly. Another suitable amount of 8% starch slurry is added to the mixed powder, mixed evenly, and then made into soft material, which is granulated through a 16-mesh sieve and dried below 60°C. After drying, use an 18-mesh sieve to sizing, sieve out the fine powder in the dry granules, mix them with the sieved magnesium stearate, and then mix them with the dry granules evenly, press the tablet, and get it.

Example Embodiment

[0029] Example 3 Preparation of gabapentin tablets

[0030]

[0031] Preparation process: Weigh the prescribed amount of gabapentin, starch, dextrin and low-substituted hydroxypropyl cellulose and mix them evenly. Take another appropriate amount of 60% ethanol, add it to the mixed powder, mix evenly to make soft material, pass through a 16-mesh sieve to granulate, and dry below 60°C. After drying, use an 18-mesh sieve to sizing, sieve out the fine powder in the dry granules, mix them with the sieved magnesium stearate, and then mix them with the dry granules evenly, press the tablet, and get it.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The application requests to protect an application of gabapentin for preparing a drug for treating or preventing ischemic cerebrovascular diseases, and belongs to the medicine field. Gabapentin is a conventional drug. According to the invention, a great many of experiments demonstrate that gabapentin can reduce NO and NOS level of an ischemic patient when the gabapentin is applied in the treatment of ischemic cerebrovascular diseases particularly cerebral ischemia or cerebral infarction, can reduce MDA content in serum, and has obvious protect effect for brain hippocampus neurons. The medical application of gabapentin can provide a novel drug selection of patients suffering from the ischemic cerebrovascular diseases, and has wide medical application prospects.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2023 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap